COMPANY NEWS
1 min read
MST Access research report
MST Access has published a research report on Lumos Diagnostics Limited.
Read article
News
Featured news
COMPANY NEWS
COMPANY NEWS
2 min read
FebriDx® Commercial Traction Continues to Advance
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
Read article
COMPANY NEWS
1 min read
REPLAY | FebriDx US Launch Update
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
Read articleAll news
COMPANY NEWS
1 min read
MST Access research report
MST Access has published a research report on Lumos Diagnostics Limited.
Read article
COMPANY NEWS
2 min read
FebriDx® Commercial Traction Continues to Advance
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
Read article
COMPANY NEWS
1 min read
REPLAY | FebriDx US Launch Update
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
Read article
COMPANY NEWS
2 min read
100+ Locations and Growing: A Milestone for FebriDx® Adoption
FebriDx® has surpassed 100 healthcare locations across 18 states in the United States
Read article
COMPANY NEWS
1 min read
Lumos Achieves 250 Patient Milestone in FebriDx® Paediatric Study
Lumos has achieved enrolment of 250 patients in its BARDA-funded FebriDx® paediatric clinical study, triggering a US$670,000 milestone payment...
Read article
COMPANY NEWS
1 min read
FebriDx® Rollout Gains Momentum with 43 New WellStreet Locations
Following the success of their initial program and supported by the recent granting of CLIA waiver for FebriDx®, WellStreet has now begun testing at 43 additional sites...
Read article
COMPANY NEWS
1 min read
REPLAY | Lumos Diagnostics Q3 FY26 Investor Briefing
Lumos Diagnostics recently hosted an investor webinar covering its Q3 FY26 financial results and operational progress.
Read article
COMPANY NEWS
1 min read
Lumos secures new contract manufacturing agreement & first purchase order with Micro-Pak®
Lumos has announced that it has secured a new three-year contract manufacturing agreement with Micro-Pak®
Read article
COMPANY NEWS
1 min read
Lumos receives largest FebriDx® order to-date from PHASE Scientific
Lumos has announced that it has now received its largest purchase order to-date for FebriDx®...
Read article
COMPANY NEWS
1 min read
FDA CLIA Waiver for FebriDx unlocks US$1B+ U.S. opportunity
Lumos Diagnostics has today announced that U.S. FDA has granted 510(k) clearance with CLIA waiver for FebriDx®, enabling broader
Read article
COMPANY NEWS
1 min read
REPLAY | Lumos Diagnostics 1H FY26 Investor Briefing
Lumos Diagnostics recently hosted an investor webinar covering its 1H FY26 financial results and operational progress.
Read article
COMPANY NEWS
1 min read
Lumos Complete 1st Enrollment Milestone for Paediatric Study
Lumos has announced the completion of the first enrollment milestone in the ongoing BARDA-funded paediatric clinical study
Read article